These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33778707)

  • 1. Monitoring Liver Tumor Ablation with MR Spectroscopy of Extracellular pH.
    Luker GD
    Radiol Imaging Cancer; 2020 Mar; 2(2):e204007. PubMed ID: 33778707
    [No Abstract]   [Full Text] [Related]  

  • 2. MR Imaging Enables Real-Time Monitoring of In Vitro Electrolytic Ablation of Hepatocellular Carcinoma.
    Stein EJ; Perkons NR; Wildenberg JC; Iyer SK; Hunt SJ; Nadolski GJ; Witschey WR; Gade TP
    J Vasc Interv Radiol; 2020 Feb; 31(2):352-361. PubMed ID: 31748127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A smart polymer for drug delivery sensitive to tumor extracellular pH.
    Chang G; Yu L; Ding J
    J Control Release; 2011 Nov; 152 Suppl 1():e4-5. PubMed ID: 22195913
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular imaging of tumor microenvironment: challenges and perspectives.
    Del Vecchio S; Zannetti A; Iommelli F; Lettieri A; Brunetti A; Salvatore M
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):249-58. PubMed ID: 20639812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-Selective in Situ Growth-Induced Self-Assembly of Protein-Polymer Conjugates into pH-Responsive Micelles for Tumor Microenvironment Triggered Fluorescence Imaging.
    Li P; Sun M; Xu Z; Liu X; Zhao W; Gao W
    Biomacromolecules; 2018 Nov; 19(11):4472-4479. PubMed ID: 30351917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of tumor pH with in vivo MR spectroscopy.
    Smith SR; Griffiths RD; Martin PA; Edwards RH
    Radiology; 1989 Nov; 173(2):572-4. PubMed ID: 2610757
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating tumor metastatic potential by imaging intratumoral acidosis via pH-activatable near-infrared fluorescent probe.
    Wang L; Fan Z; Zhang J; Changyi Y; Huang C; Gu Y; Xu Z; Tang Z; Lu W; Wei X; Li C
    Int J Cancer; 2015 Feb; 136(4):E107-16. PubMed ID: 25155456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T.
    Harris RJ; Cloughesy TF; Liau LM; Nghiemphu PL; Lai A; Pope WB; Ellingson BM
    NMR Biomed; 2016 Nov; 29(11):1563-1576. PubMed ID: 27717216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-based monitoring of magnetic resonance-guided thermoablative therapies for liver tumors.
    Rempp H; Clasen S; Pereira PL
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1281-94. PubMed ID: 21785888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI of the tumor microenvironment.
    Gillies RJ; Raghunand N; Karczmar GS; Bhujwalla ZM
    J Magn Reson Imaging; 2002 Oct; 16(4):430-50. PubMed ID: 12353258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pH and thermosensitive choline phosphate-based delivery platform targeted to the acidic tumor microenvironment.
    Yu X; Yang X; Horte S; Kizhakkedathu JN; Brooks DE
    Biomaterials; 2014 Jan; 35(1):278-86. PubMed ID: 24112803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional MR imaging as a new paradigm for image guidance.
    Assumpcao L; Choti M; Pawlik TM; Gecshwind JF; Kamel IR
    Abdom Imaging; 2009 Nov; 34(6):675-85. PubMed ID: 19048335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of magnetic resonance techniques for imaging tumour physiology.
    Stubbs M
    Acta Oncol; 1999; 38(7):845-53. PubMed ID: 10606414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
    Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
    Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.
    Segebarth CM; Balériaux DF; Arnold DL; Luyten PR; den Hollander JA
    Radiology; 1987 Oct; 165(1):215-9. PubMed ID: 3628774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery.
    Zhu H; Zhang S; Ling Y; Meng G; Yang Y; Zhang W
    J Control Release; 2015 Dec; 220(Pt A):529-544. PubMed ID: 26590349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH.
    Anemone A; Consolino L; Arena F; Capozza M; Longo DL
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):25-49. PubMed ID: 30762162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated ratiometric fluorescent probe for pH mapping of malignant tumors.
    Hou Y; Zhou J; Gao Z; Sun X; Liu C; Shangguan D; Yang W; Gao M
    ACS Nano; 2015 Mar; 9(3):3199-205. PubMed ID: 25670342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular pH measured by
    Wenger KJ; Hattingen E; Franz K; Steinbach JP; Bähr O; Pilatus U
    J Magn Reson Imaging; 2017 Oct; 46(4):1200-1208. PubMed ID: 28165649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnetic resonance imaging and magnetic resonance spectroscopy methods for measuring intra- and extra-cellular pH: clinical implications].
    Ballesteros P; Pérez-Mayoral E; Benito M; Cerdán S
    Radiologia; 2008; 50(6):463-70; quiz 470. PubMed ID: 19100206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.